New scan could tell doctors if cancer treatment will work
NCT ID NCT03564197
Summary
This study tested whether a special type of PET scan could predict which patients with advanced non-small cell lung cancer (NSCLC) would respond well to immunotherapy drugs like nivolumab. Eighty patients received the scan before starting treatment to see if it could accurately forecast who would have long-term benefits. The goal was to gather knowledge to help doctors choose the right treatment for each patient, potentially avoiding ineffective therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antoni van Leeuwenhoek
Amsterdam, 1060CX, Netherlands
-
Antonius Ziekenhuis
Utrecht, Netherlands
-
Deventer Ziekenhuis
Deventer, Netherlands
-
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
-
LUMC
Leiden, Netherlands
-
MeanderMC
Amersfoort, Netherlands
-
Medisch Centrum Haaglanden
The Hague, Netherlands
-
VUmc
Amsterdam, 1007 MB, Netherlands
Conditions
Explore the condition pages connected to this study.